[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

about

Atopic dermatitis-like skin lesions reduced by topical application and intraperitoneal injection of Hirsutenone in NC/Nga mice.Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in NC/Nga mice.

P2860

Q34442932-AF322760-04FA-48FE-9E45-0377100FA8D3 Q35488214-79F23DA3-C12F-47BA-80EB-EFA162FB0986

P2860

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

Item

http://www.wikidata.org/entity/Q44420855

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@en

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@nl

type

Item

label

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@en

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@nl

prefLabel

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@en

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@nl

P1476

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

@en

P2093

D Thaçi

http://www.w3.org/2001/XMLSchema#string

P2860

Managing pediatric atopic dermatitis.

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.

Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment.

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients.

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.

P2888

s00105-003-0524-3

P304

418-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00105-003-0524-3

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12719861

http://www.w3.org/2001/XMLSchema#string

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

about

P2860

P2860

[Long term management of childhood atopic dermatitis with calcineurin inhibitors].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698